18 and older, any sex, with Dental Plaque Induced Gingivitis or Dental Plaque. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Plaque IndexPrimary· Baseline, 1 month
plaque index as evaluated by Silness-Loe Index: index recording both soft debris and mineralized deposits on teeth (index 0 (no plaque) to 3).
Baseline
Group
Value
95% CI
Pulsating Toothbrush
1.07
± 0.24
Sonic Toothbrush
1.19
± 0.25
Manual Toothbrush
1.31
± 0.27
1 Month
Group
Value
95% CI
Pulsating Toothbrush
1.11
± 0.27
Sonic Toothbrush
1.27
± 0.40
Manual Toothbrush
1.20
± 0.24
Gingival IndexPrimary· Baseline, 1 month
gingival index as evaluated by Silness-Loe Index, Range 0-3: Score 0 = Normal gingiva. Score 1 = Mild inflammation - slight change in color, slight edema. No bleeding on probing.
Score 2 = Moderate inflammation - redness, edema, glazing. Bleeding on probing. Score 3 = Severe inflammation - marked redness and edema, ulceration. Tendency toward spontaneous bleeding.
Baseline
Group
Value
95% CI
Manual Toothbrush
0.42
± 0.41
Sonic Toothbrush
0.35
± 0.41
Pulsating Toothbrush
0.36
± 0.39
1 Month
Group
Value
95% CI
Manual Toothbrush
0.22
± 0.16
Sonic Toothbrush
0.16
± 0.16
Pulsating Toothbrush
0.14
± 0.13
Sponsor's own description
It is well accepted that the greatest contributor to the health of the periodontium and dentition is regular and thorough dental plaque removal, typically by means of adequate toothbrushing. Although patients are typically informed about the risks of substandard oral hygiene and the contributing factors in oral/dental disease by dental professionals, research has shown that an undesirably high proportion of adults find thorough toothbrushing with a standard manual toothbrush to achieve a plaque-free state challenging, as evidenced by high worldwide levels of gingivitis and/or periodontitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
Last refreshed: 24 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03416985.